Additional Information
Book Details
Abstract
This issue of Radiologic Clinics will focus on the essentials of thoracic imaging. Topics include lung cancer screening and staging systems, radiation dose techniques, nodule characterization, PET/CT in the thorax, MDCT and MR evaluation of thoracic aorta, pulmonary emboli and perfusion imaging, interstital pneumonias, emphysema and airway imaging, post-operative chest, and thoracic infections in the immunocompromised host.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Contributors | iii | ||
Consulting Editor | iii | ||
Editor | iii | ||
Authors | iii | ||
Contents | vii | ||
Prefacexiii | vii | ||
Radiation Dose Optimization and Thoracic Computed Tomography1 | vii | ||
PET/CT in the Thorax: Pitfalls17 | vii | ||
Lung Cancer Screening with Low-Dose Computed Tomography27 | vii | ||
Nodule Characterization: Subsolid Nodules47 | vii | ||
The Clinical Staging of Lung Cancer Through Imaging: A Radiologist’s Guide to the Revised Staging System and Rationale for ... | viii | ||
Imaging the Post-Thoracotomy Patient: Anatomic Changes and Postoperative Complications85 | viii | ||
The Idiopathic Interstitial Pneumonias: An Update and Review105 | viii | ||
Thoracic Infections in Immunocompromised Patients121 | viii | ||
Multidetector Computed Tomographic Imaging in Chronic Obstructive Pulmonary Disease: Emphysema and Airways Assessment137 | ix | ||
Congenital Lung Anomalies in Children and Adults: Current Concepts and Imaging Findings155 | ix | ||
New Insights in Thromboembolic Disease183 | ix | ||
Thoracic Aorta (Multidetector Computed Tomography and Magnetic Resonance Evaluation)195 | ix | ||
Program Objective | x | ||
Target Audience | x | ||
Learning Objectives | x | ||
Accreditation | x | ||
Disclosure of Conflicts of Interest | x | ||
Unapproved/Off-Label Use Disclosure | xi | ||
To Enroll | xi | ||
Method of Participation | xi | ||
CME Inquiries/Special Needs | xi | ||
Preface | xiii | ||
Radiation Dose Optimization and Thoracic Computed Tomography | 1 | ||
Key points | 1 | ||
Introduction | 1 | ||
Techniques for dose reduction | 2 | ||
Conventional techniques for dose reduction | 2 | ||
Making Indication-Specific Protocols | 2 | ||
Number of Scanning Passes | 2 | ||
Optimal Patient Centering | 2 | ||
Step-and-Shoot Versus Helical Scanning | 3 | ||
Tube Current | 3 | ||
AEC | 5 | ||
Tube Potential | 6 | ||
Scan Length | 6 | ||
Gantry Rotation Time | 7 | ||
Scan Pitch and Detector Collimation | 7 | ||
Image Noise Reduction Filters | 7 | ||
Contemporary techniques | 8 | ||
Iterative Reconstruction Techniques | 8 | ||
Automatic Tube Potential Selection | 11 | ||
High-Pitch Scanning | 11 | ||
Organ-Based Dose Modulation | 12 | ||
Summary | 12 | ||
References | 12 | ||
PET/CT in the Thorax | 17 | ||
Key points | 17 | ||
Introduction | 17 | ||
Technical artifacts | 18 | ||
Physiologic FDG uptake | 18 | ||
Striated Muscle | 19 | ||
Brown Fat | 19 | ||
PET negative malignancy | 20 | ||
False-positive FDG uptake | 21 | ||
Infection and Inflammation | 21 | ||
Iatrogenic | 23 | ||
Summary | 24 | ||
References | 24 | ||
Lung Cancer Screening with Low-Dose Computed Tomography | 27 | ||
Key points | 27 | ||
Introduction | 27 | ||
Guidelines for lung cancer screening | 29 | ||
Who should be screened? | 29 | ||
CT scanning techniques | 31 | ||
Nodule measurement and characterization | 32 | ||
Growth Rates of Nodules | 35 | ||
Management of patients | 36 | ||
Incidental findings | 37 | ||
Chronic Obstructive Pulmonary Disease | 37 | ||
Coronary Artery Calcification | 40 | ||
Other Cancers | 40 | ||
Reporting results | 41 | ||
Barriers to screening | 42 | ||
Financial Costs | 42 | ||
Risks Associated with CT Screening | 42 | ||
Radiation exposure | 42 | ||
Overdiagnosis | 43 | ||
Smoking Behaviors | 43 | ||
False positives | 43 | ||
Summary | 44 | ||
References | 44 | ||
Nodule Characterization | 47 | ||
Key points | 47 | ||
Definitions and terminology | 47 | ||
Epidemiology | 48 | ||
Etiology | 48 | ||
Transient Subsolid Nodules | 48 | ||
Persistent Subsolid Nodules | 48 | ||
Lung adenocarcinoma: new revised histologic classification | 49 | ||
Extrathoracic metastases | 50 | ||
Inflammatory etiologies | 51 | ||
CT technique | 52 | ||
CT characterization | 54 | ||
Size, Internal Characteristics, and Associated Findings | 54 | ||
Nodule Attenuation | 55 | ||
Nodule Measurement, Growth, and Follow-up | 58 | ||
Role of PET-CT and transthoracic/transbronchial biopsy | 59 | ||
Management of subsolid nodules | 60 | ||
Surgical Resection | 62 | ||
Summary | 62 | ||
References | 62 | ||
The Clinical Staging of Lung Cancer Through Imaging | 69 | ||
Key points | 69 | ||
Introduction | 69 | ||
IASLC population and methodology | 70 | ||
T classification | 70 | ||
N classification | 74 | ||
M classification | 75 | ||
SCLC | 75 | ||
Bronchopulmonary carcinoid tumors | 77 | ||
Changes to the staging system | 77 | ||
Role of imaging in lung cancer | 77 | ||
Summary | 82 | ||
References | 82 | ||
Imaging the Post-Thoracotomy Patient | 85 | ||
Key points | 85 | ||
Introduction | 85 | ||
Pulmonary resection | 85 | ||
Partial Lung Resection | 86 | ||
Pneumonectomy | 86 | ||
Early post-thoracotomy complications | 88 | ||
Postpneumonectomy Pulmonary Edema | 88 | ||
Acute Lung Injury/Acute Respiratory Distress Syndrome | 90 | ||
Pneumonia | 92 | ||
Bronchopleural Fistula | 93 | ||
Empyema | 93 | ||
Hemothorax | 94 | ||
Lobar Torsion | 95 | ||
Cardiac Herniation | 96 | ||
Late post-thoracotomy complications | 97 | ||
Postpneumonectomy Syndrome | 97 | ||
Pulmonary Artery Stump Thrombosis | 99 | ||
Late Bronchopleural Fistula and Empyema | 99 | ||
Gossypiboma | 100 | ||
Summary | 101 | ||
References | 101 | ||
The Idiopathic Interstitial Pneumonias | 105 | ||
Key points | 105 | ||
Introduction | 105 | ||
Multidisciplinary approach | 105 | ||
Chronic fibrosing interstitial lung disease | 108 | ||
UIP | 108 | ||
NSIP | 111 | ||
Smoking-related interstitial pneumonias | 112 | ||
RB and RB-ILD | 112 | ||
DIP | 113 | ||
Acute and subacute interstitial pneumonias | 114 | ||
COP | 114 | ||
AIP | 114 | ||
Rare interstitial pneumonias | 115 | ||
LIP | 115 | ||
IPPFE | 116 | ||
Summary | 117 | ||
References | 117 | ||
Thoracic Infections in Immunocompromised Patients | 121 | ||
Key points | 121 | ||
Introduction | 121 | ||
Type of immune defects and specific patient population | 122 | ||
Hematological malignancies and blood stem cell transplantation | 122 | ||
Preengraftment Period (Days 0–30) | 122 | ||
Early Posttransplantation Period (Days 31–100) | 123 | ||
Late Posttransplantation Period (Beyond Day 100) | 123 | ||
Lung transplant | 123 | ||
Bacterial Pneumonia | 124 | ||
Viral Pneumonia | 124 | ||
Fungal Pneumonia | 125 | ||
HIV infection | 126 | ||
Bacterial Pneumonia | 126 | ||
Pneumocystis Pneumonia | 127 | ||
Mycobacterium tuberculosis and Nontuberculous Mycobacteria | 127 | ||
Fungal Infections Other than PJP | 128 | ||
Viral and Parasitic Infections | 128 | ||
Solid organ transplant | 128 | ||
Bacterial Pneumonia | 129 | ||
Viral Pneumonia | 129 | ||
Fungal Pneumonia | 130 | ||
Radiologic manifestations | 131 | ||
Fungal Pneumonia | 131 | ||
Aspergillosis | 131 | ||
Candidiasis | 131 | ||
Cryptococcosis (C neoformans) | 131 | ||
Pneumocystis pneumonia | 132 | ||
Bacterial Pneumonia | 132 | ||
Nocardiosis | 132 | ||
M tuberculosis | 132 | ||
Nontuberculous mycobacteria | 132 | ||
Viral Pneumonia | 133 | ||
Summary | 133 | ||
References | 133 | ||
Multidetector Computed Tomographic Imaging in Chronic Obstructive Pulmonary Disease | 137 | ||
Key points | 137 | ||
Introduction | 137 | ||
CT Imaging in COPD | 138 | ||
CT technique | 138 | ||
CT in Emphysema | 140 | ||
Definitions | 140 | ||
CT findings in emphysema | 141 | ||
CT and qualitative (subjective) assessment of emphysema | 141 | ||
CT and quantitative (objective) assessment of emphysema | 143 | ||
Factors influencing CT densitometry | 144 | ||
End-inspiratory and end-expiratory CT acquisition in emphysema | 144 | ||
Clinical importance of CT emphysema assessment and quantification | 145 | ||
Airway Imaging in COPD | 145 | ||
Definition and pathologic changes | 145 | ||
Qualitative (subjective) assessment of airways | 145 | ||
Quantitative (objective) assessment of airways | 145 | ||
Trachea and COPD | 147 | ||
Imaging in classification of COPD | 148 | ||
COPD and systemic inflammation | 148 | ||
Summary | 148 | ||
Acknowledgments | 149 | ||
References | 149 | ||
Congenital Lung Anomalies in Children and Adults | 155 | ||
Key points | 155 | ||
Introduction | 155 | ||
Current concepts regarding the underlying causes of congenital lung anomalies | 156 | ||
Imaging techniques | 156 | ||
Plain Radiographs | 156 | ||
US | 157 | ||
Prenatal US | 157 | ||
Postnatal US | 157 | ||
Computed Tomography | 157 | ||
MR Imaging | 158 | ||
Prenatal MR imaging | 158 | ||
Postnatal MR imaging | 159 | ||
Imaging spectrum of congenital lung anomalies | 159 | ||
Vascular Anomalies | 159 | ||
Pulmonary arterial anomalies | 159 | ||
Pulmonary agenesis, aplasia, and hypoplasia | 159 | ||
Proximal interruption of the pulmonary artery | 161 | ||
Pulmonary artery sling | 161 | ||
Pulmonary venous anomalies | 163 | ||
Partial anomalous pulmonary venous return | 163 | ||
Pulmonary varix | 164 | ||
Pulmonary vein stenosis | 165 | ||
Combined pulmonary arterial and venous anomaly | 165 | ||
Pulmonary arteriovenous malformation | 165 | ||
Parenchymal Anomalies | 167 | ||
Congenital bronchial atresia | 167 | ||
Foregut duplication cyst | 167 | ||
CLH | 169 | ||
CPAM | 171 | ||
Combination of Vascular and Parenchymal Anomalies | 174 | ||
Pulmonary sequestration | 174 | ||
Hypogenetic lung syndrome (scimitar syndrome) | 177 | ||
Summary | 178 | ||
References | 178 | ||
New Insights in Thromboembolic Disease | 183 | ||
Key points | 183 | ||
Introduction | 183 | ||
Diagnostic approach | 183 | ||
Detection of Peripheral Clots | 184 | ||
Are All Clots Equally Important on a Chest CT Angiographic Examination? | 184 | ||
Practical aspects for risk stratification on CT examinations | 185 | ||
Right Ventricular Dysfunction | 185 | ||
Pulmonary Vascular Obstruction | 186 | ||
New saving options | 187 | ||
Savings in Radiation Dose | 187 | ||
Savings in Contrast Material | 188 | ||
Pulmonary embolism from pregnancy to young adulthood | 189 | ||
Pulmonary Embolism in Pregnancy | 189 | ||
Pulmonary Embolism in Children | 190 | ||
Summary | 190 | ||
References | 190 | ||
Thoracic Aorta (Multidetector Computed Tomography and Magnetic Resonance Evaluation) | 195 | ||
Key points | 195 | ||
Introduction | 195 | ||
Normal anatomy and variations | 196 | ||
CT | 196 | ||
Multidetector CT Technology and Electrocardiographic Gating | 196 | ||
CTA | 197 | ||
Iodinated Contrast Material Considerations | 197 | ||
Dual-Energy CT Scanning | 198 | ||
Newer CT Image Reconstruction Techniques | 198 | ||
Radiation Considerations | 198 | ||
Supplemental Image Evaluation | 199 | ||
Centerline vessel analysis | 199 | ||
Maximum intensity projection, volume rendering, and multiplanar reformatted images | 199 | ||
Postprocessing for transcatheter aortic valve replacement | 200 | ||
MR imaging | 201 | ||
Black Blood Imaging | 201 | ||
Bright Blood Imaging | 201 | ||
Flow Mapping | 201 | ||
Gadolinium-Enhanced MRA | 203 | ||
Unenhanced MRA | 204 | ||
Novel Use of Aortic MR Imaging Techniques | 204 | ||
Imaging findings of disease | 204 | ||
Classic Double-Barrel Dissection | 204 | ||
IMH | 205 | ||
PAU | 208 | ||
Aneurysm | 208 | ||
Trauma | 210 | ||
Aortitis | 211 | ||
Postoperative Imaging | 212 | ||
Aortic Malignancy | 213 | ||
Practice patterns | 213 | ||
Summary | 213 | ||
Acknowledgments | 213 | ||
References | 213 | ||
Index | 219 | ||
A | 219 | ||
B | 219 | ||
C | 219 | ||
D | 220 | ||
E | 220 | ||
F | 220 | ||
G | 221 | ||
H | 221 | ||
I | 221 | ||
L | 221 | ||
M | 222 | ||
N | 222 | ||
O | 223 | ||
P | 223 | ||
R | 224 | ||
S | 224 | ||
T | 224 | ||
U | 225 | ||
V | 225 |